ROIV

ROIV

USD

Roivant Sciences Ltd. Common Shares

$19.870+0.320 (1.637%)

Precio en Tiempo Real

Healthcare
Biotecnología
Reino Unido

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$19.550

Máximo

$19.890

Mínimo

$19.315

Volumen

9.01M

Fundamentos de la Empresa

Capitalización de Mercado

13.6B

Industria

Biotecnología

País

United Kingdom

Estadísticas de Negociación

Volumen Promedio

7.66M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $8.73Actual $19.870Máximo $20.085

Noticias Relacionadas

GlobeNewswire

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update.

Ver más
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
Analyst Upgrades

Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25

Citigroup analyst Samantha Semenkow maintains Roivant Sciences with a Buy and raises the price target from $16 to $25.

Ver más
Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25
GlobeNewswire

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.

Ver más
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
GlobeNewswire

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

BASEL, Switzerland and LONDON and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 10, 2025, to

Ver más
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.